Skip to content

NIH MD/PHD Partnership Training Program

Meet the Directors

 

Meet the Directors

The NIH MD/PhD Partnership Training Program is run by a dedicated team of NIH faculty and administrators. As a part of the NIH Global Doctoral Partnerships we share activities and staff with the NIH Oxford-Cambridge Scholars Program and the NIH-Wellcome Trust PhD Studentships. Students in the program are assigned to a faculty advisor from our advisory commitee below.

Please feel free to contact us at any time. The program is housed in building 15F1 at north end of the NIH campus, informally known as 'The Cottage'. Please stop by and visit if you are on Campus.

 


 

Program Advisory Committee

Craig Blackstone Craig Blackstone, M.D., Ph.D.
Director, NIH MD/PhD Partnership Training Program
Senior Investigator, National Institute of Neurological Disorders and Stroke
Research Interest: Cell Biology
Clinical Training: Neurology
Craig Blackstone, MD, PhD is Senior Investigator at the NINDS as well as Director of the NIH MD-PhD Partnership Training Program.  He received BS and MS degrees in 1987 from the University of Chicago, where he was awarded the Sigma Xi Award for Excellence in Undergraduate Research.  He was awarded a Medical Scientist Training Program Fellowship at the Johns Hopkins University School of Medicine, where he completed MD and PhD degrees in 1994.  His graduate studies in the laboratory of Dr. Richard Huganir were on the structure and regulation of glutamate receptors in the central nervous system, for which he received the David Israel Macht Research Award.  After a neurology residency in the Harvard-Longwood Neurology Program, Dr. Blackstone pursued fellowship training in movement disorders at the Massachusetts General Hospital and postdoctoral research training with Dr. Morgan Sheng at Harvard Medical School.  In 2001, Dr. Blackstone joined the NINDS Clinical Neurosciences Program.  His laboratory focuses on the cellular and molecular mechanisms underlying the hereditary spastic paraplegias, and the cellular regulation of mitochondrial fission and fusion in both normal and neurological disease states.  He served on the Executive Council of the American Neurological Association from 2008-2011 and is currently Co-Director of the American Neurological Association's Annual Translational and Clinical Research Course in the Neurosciences.   He is an elected member of the American Society for Clinical Investigation and serves on the Scientific Advisory Board of the Spastic Paraplegia Foundation and the Board of Consulting Editors for the Journal of Clinical Investigation.  In 2012, Dr. Blackstone received the NIH Director's Ruth L. Kirschstein Mentoring Award.

Richard Siegel Richard Siegel, M.D., Ph.D.
Senior Advisor, NIH MD/PhD Partnership Program
Senior Investigator,National Institute of Arthritis and Musculoskeletal and Skin Disease
Research Interest: Immunology
Clinical Training: Rheumatology
Richard Siegel, MD, PhD, trained at the University of Pennsylvania, initially as an M.D./Ph.D. student in immunology and then as a resident in internal medicine and rheumatology fellow. He moved to the NIH in 1996 to do postdoctoral training with Michael Lenardo in the Laboratory of Immunology in the National Institute of Allergy and Infectious Disease. There he studied apoptosis signaling and the molecular basis of its impairment in patients with inherited mutations in Fas/CD95 and the Autoimmune Lymphoprolieferative Syndrome (ALPS). In 2001, Dr. Siegel moved to NIAMS as a tenure-track investigator. His current research interests include regulation of cellular survival and death in immune system by TNF receptor and other signaling pathways, and the relevance of these pathways to autoimmune diseases and immune tolerance. He is a member of the American Society of Clinical Investigation and has served on the editorial board of the Journal of Biological Chemistry. In 2006, with Michael Lenardo, Dr. Siegel  founded the MD/PhD partnership training program

Brian Kelsall Brian Kelsall, MD
Senior Investigator, National Institute of Allergy and Infectious Diseases
Research Interest: Immunology
Clinical Training: Internal Medicine/ Infectious Diseases
Dr. Brian Kelsall received his B.A. in human biology from Stanford University in 1982. In 1986, he earned his M.D. from Case Western Reserve University School of Medicine. He did postdoctoral training in internal medicine at The New York Hospital-Cornell Medical Center from 1986 to 1989 and in infectious diseases at the University of Virginia Medical Center from 1989 to 1992. In 1992, Dr. Kelsall went to the National Institutes of Health, completed fellowship training in mucosal immunology in 1996, and became a senior investigator in 2003. His research focuses on the regulation of immune responses in the intestine, in particular the role that unique intestinal dendritic cell and macrophage populations play in the induction of immunity to intestinal viral pathogens and mucosal vaccines and in the pathogenesis of inflammatory bowel disease.

Alan Michelson Daniel Reich, MD, PhD
Chief, Translational Neuroradiology Unit, Neuroimmunology Brach
National Institute of Neurological Disorders and Stroke
 Daniel Reich – a neurologist and neuroradiologist – directs the Translational Neuroradiology Unit in the National Institute of Neurological Disorders and Stroke, part of NIH. In his clinical practice, he cares for patients with multiple sclerosis and other neurological diseases, and he also leads several clinical studies focusing on multiple sclerosis. Research in his lab focuses on the use of advanced MRI techniques to understand the sources of disability in multiple sclerosis and on ways of adapting those approaches for research trials and patient care. He is particularly interested in harnessing noninvasive imaging modalities to dissect biological mechanisms of tissue damage.

Pam Schwartzberg

Pam Schwartzberg, MD, PhD
Chief & Senior Investigator,
Genetic Disease Research Branch,
Head, Cell Signaling and Immunity Section
National Human Genome Research Institute

 Dr. Schwartzberg received her MD-PhD from Columbia College of Physicians and Surgeons. Her laboratory studies signal transduction pathways in T lymphocytes with a focus on pathways affected in primary immunodeficiencies. Most recently, her laboratory has helped uncover new insight into the pathophysiology of primary immunodeficiencies including X-linked Lymphoproliferative Disease (Immunity, 2012; Nature 2008; J. Immunol 2013), Itk-deficiency (Immunity 2009; JEM 2014) and a new immunodeficiency associated with activated PI3K mutations (Nat. Immunol 2014). She has also been active in the NIH Center for Human Immunology, where she helped co-lead a major study on responses to influenza immunization in humans (Cell, 2014). Dr. Schwartzberg has received numerous awards for her work including election to the American Society for Clinical Investigation and the American Association of Physicians and the BD Biosciences Award from the American Association of Immunologists.

 Pam Schwartzberg

Helen Su, MD, PhD
Chief, Human Immunological Diseases Unit,
Laboratory of Host Defenses,
National Institute of Allergy and Infectious Diseases

Dr. Helen Su received M.D. and Ph.D. degrees from Brown University. She completed training in pediatrics at St. Louis Children’s Hospital, Washington University, and subspecialty training in allergy and immunology at NIAID. After postdoctoral training in the Laboratory of Immunology, she joined the Laboratory of Host Defenses in 2007 as a tenure-track clinical investigator. Her laboratory focuses on understanding the molecular mechanisms regulating the human immune system and how their derangements cause disease, with the objective of improving diagnosis and treatment. Currently they are working on studying patients with a spectrum of poorly characterized, inherited immunodeficiencies and autoimmune diseases, who lack molecular diagnoses. Dr. Su’s lab has established close collaborations with several groups at the NIH to study these rare diseases, including the Laboratory of Immunology and the Laboratory of Clinical Infectious Diseases within NIAID and others outside NIH.

Carter Van Waes

Carter Van Waes, MD, PhD
Chief, Head and Neck Surgery Branch
Clinical Director,
National Institute on Deafness and Other Communication Disorders

 Dr. Van Waes received a B.A. in Chemistry with honors from Earlham College in 1980. He received an M.D., and Ph.D. in Immunology of cancer with Honors from University of Chicago in 1987, supported by the NIH MSTP. He completed a NIH post-doctoral fellowship in molecular biology of head and neck cancer in 1990, and residency in Otolaryngology-Head and Neck Surgery at University of Michigan in 1993. He joined NIDCD in 1993 as a Senior Staff Fellow; was promoted to Investigator in 1995, and Senior Investigator and Chief of the Head and Neck Surgery Branch in 2003. His research integrates basic and clinical investigation of genomics, signaling, molecular, and immune targeted therapy of cancer.

About